- Home
- TGNA vs ALVO Comparison
TGNA vs ALVO Comparison
Compare TGNA & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGNA
- ALVO
- Stock Information
- Founded
- TGNA 1906
- ALVO 2013
- Country
- TGNA United States
- ALVO Luxembourg
- Employees
- TGNA N/A
- ALVO N/A
- Industry
- TGNA Broadcasting
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- TGNA Industrials
- ALVO Health Care
- Exchange
- TGNA Nasdaq
- ALVO Nasdaq
- Market Cap
- TGNA 2.9B
- ALVO 3.4B
- IPO Year
- TGNA N/A
- ALVO N/A
- Fundamental
- Price
- TGNA $17.97
- ALVO $13.27
- Analyst Decision
- TGNA Buy
- ALVO Buy
- Analyst Count
- TGNA 3
- ALVO 1
- Target Price
- TGNA $21.67
- ALVO $18.00
- AVG Volume (30 Days)
- TGNA 1.5M
- ALVO 184.6K
- Earning Date
- TGNA 02-27-2025
- ALVO 11-13-2024
- Dividend Yield
- TGNA 2.72%
- ALVO N/A
- EPS Growth
- TGNA N/A
- ALVO N/A
- EPS
- TGNA 2.81
- ALVO N/A
- Revenue
- TGNA $2,957,296,000.00
- ALVO $393,919,000.00
- Revenue This Year
- TGNA $8.66
- ALVO $398.12
- Revenue Next Year
- TGNA N/A
- ALVO $44.73
- P/E Ratio
- TGNA $6.40
- ALVO N/A
- Revenue Growth
- TGNA N/A
- ALVO 517.92
- 52 Week Low
- TGNA $12.35
- ALVO $9.15
- 52 Week High
- TGNA $19.62
- ALVO $18.00
- Technical
- Relative Strength Index (RSI)
- TGNA 44.03
- ALVO 62.47
- Support Level
- TGNA $17.73
- ALVO $13.06
- Resistance Level
- TGNA $18.70
- ALVO $13.50
- Average True Range (ATR)
- TGNA 0.39
- ALVO 0.35
- MACD
- TGNA -0.07
- ALVO 0.00
- Stochastic Oscillator
- TGNA 19.67
- ALVO 64.17
About TGNA TEGNA Inc
Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.